HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Capital Fund II, LP into HAPPE Spine.
HOLLAND, Mich., July 10, 2018—Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SafKan Health, Inc.
Holland-based Genesis Innovation Group LLC raised $7.2 million of its $10 million goal toward a fund to invest in early stage health care companies, particularly those developing medical devices and orthopedic technologies.
The organizers behind the new cultivate(MD) Capital Fund GP LLC found backers by appealing to their own global professional networks and investors with whom they had previously done business.
Many of the approximately 50 investors in the Holland-based venture capital fund are individuals who invested previously in startups spun out of Genesis Innovation Group LLC, a Holland-based developer of emerging medical device technologies whose partners formed cultivate(MD) last fall.
A Holland-based venture capital firm closed last week on $7.2 million of the $10 million it seeks to raise to invest in health care startups.
Formed last fall by Genesis Innovation Group LLC, a developer of emerging medical device technologies, cultivate(MD) Capital Fund GP LLC netted investments from about 50 individual investors. Many investors are individuals who invested previously in startups spun out of Genesis Innovation Group, said Robert Ball, CEO of Genesis and managing director of cultivate(MD).
Genesis Innovation Group and cultivate (MD) Capital Funds are dedicated to bringing emerging health care innovations to market. HOLLAND, Mich., March 6, 2018 —Genesis Innovation Group, LLC, (Genesis) an emerging developer of medical device technologies, today announced that cultivate(MD) Capital Fund GP, LLC (cultivate(MD)), has closed its first tranche of $7.2M in capital funds ofRead more about cultivate(MD) Capital Funds Announces First Tranche Closing […]
HOLLAND, Mich., December 2017 – Shoulder Innovations, an emerging developer of shoulder replacement systems, today announced it closed a $1.6 million round of Series A equity funding. Demand for the company’s innovative shoulder replacement technology continues to grow, driving Shoulder Innovations’ sales revenues more than 380% during 2017.
Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million
Wright Medical Group N.V. today announced the acquisition of IMASCAP SAS, a leader in the development of software-based solutions for preoperative planning of shoulder replacement surgery.
$10 Million Fund is dedicated to bringing emerging healthcare innovations to market.
HOLLAND, Mich., November 28, 2017—
Genesis Innovation Group, LLC, an emerging developer of medical device technologies, today announced the formation of cultivate(MD) Capital Fund I, LLC, a venture capital fund focused on investing in early-stage healthcare companies, with special focus on medical device and orthopedic technologies. cultivate(MD) LLC is expected to manage $10M, is limited to private placements, and closed to the public. Genesis anticipates the cultivate(MD) fund to be fully operational and actively seeking companies in which to invest by early 2018.
GRAND RAPIDS, Mich., August 24, 2017—Genesis Innovation Group today announced a strategic partnership with Spectrum Health Innovations (SHI) to bring a new and innovative shoulder brace to market. This is the first partnership between the two organizations.
Genesis Innovation Group is a global team of engineers and industry professionals, based in Holland, Michigan, who work with medical device entrepreneurs on product development, manufacturing, commercialization, distribution and other business needs essential to their success.